32 results
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
10 Jan 24
Material Modifications to Rights of Security Holders
4:16pm
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
19 May 23
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
24 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
EX-3.1
SEEL
Seelos Therapeutics Inc
21 May 21
Material Modifications to Rights of Security Holders
4:29pm
8-K/A
EX-3.1
w8zz4r6p 84rr53t8g6
21 May 20
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-3.1
jtk3e r14fkznqn8y
19 May 20
Material Modifications to Rights of Security Holders
8:30am
8-K
EX-3.1
rrdp3x61xzuv
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
EX-3.3
7fysf9znm uyxo
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
EX-3.2
utxygr
24 Jan 19
Completion of Acquisition or Disposition of Assets
8:05am
8-K
EX-3.1
6zxco
16 Oct 18
Entry into a Material Definitive Agreement
8:57pm
425
EX-3.1
ogs2glp4
16 Oct 18
Business combination disclosure
8:56pm
8-K
EX-3.1
sr2c9sc5s3
25 Oct 16
Apricus Biosciences Announces 1-for-10 Reverse Stock Split
12:00am
8-K
EX-3.1
e80lx 2rg
7 Mar 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
as1iexg 6fftpgd
13 Jan 16
Apricus Biosciences Announces $10 Million Registered Direct Offering
12:00am
SC 13D
EX-3
kacpro kh8hb
23 Feb 15
Beneficial ownership report
12:00am
8-K
EX-3.1
gx848yq6q6
16 May 13
Entry into a Material Definitive Agreement
12:00am